Wistar scientists move HIV vaccine research forward by developing an immunogen that produces tier-2 antibodies—the kind that matter for combatting HIV
PHILADELPHIA — (Feb. 4, 2022) — Nearly four decades after its discovery, HIV has killed 36.3 million people, with no ...